Pharmecons is an international outcomes research agency specializing in health technology assessment issues, health economics and patient-reported outcomes (PRO). We are based in the UK, with academic links around Europe. We have extensive experience in building Markov and other decision-analytic models, discrete choice experiments, utility elicitation and other health technology assessment tools. The main focus of the consultancy is the evaluation of healthcare technologies and the role in HOSMARTAI is the identification of Key Performance Indicators of the AI technologies and the economic evaluation of HOSMARTAI technologies from the perspective of the social European Healthcare System.
